glucuronic acid has been researched along with Spinal Cord Injuries in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (20.00) | 29.6817 |
2010's | 12 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blesch, A; Chtarto, A; Liu, S; Müller, R; Nicholson, L; Puttagunta, R; Sandner, B; Schackel, T; Tenenbaum, L; Weidner, N | 1 |
Blaško, J; Cizkova, D; Kafka, J; Slovinska, L; Szekiova, E | 1 |
Baek, SR; Jeon, SR; Kim, SW; Kwon, IK; Min, J; Park, JH | 1 |
Ansorena, E; Blanco-Prieto, MJ; De Berdt, P; des Rieux, A; Deumens, R; Jacobs, D; Jankovski, A; Préat, V; Schakman, O; Simón-Yarza, T; Ucakar, B | 1 |
Donius, AE; Francis, NL; Hunger, PM; Wegst, UG; Wheatley, MA | 1 |
Blaško, J; Cizkova, D; Cohen, S; Devaux, S; Fournier, I; Grulova, I; Kryukov, O; Salzet, M; Slovinska, L; Wisztorski, M | 1 |
Koffler, J; Lynam, DA; Sakamoto, JS; Shahriari, D; Tuszynski, MH | 1 |
Beiermeister, R; Doberenz, F; Galli, R; Gelinsky, M; Kirsch, M; Koch, E; Later, R; Leipnitz, E; Sablinskas, V; Schackert, G; Sitoci-Ficici, KH; Steiner, G; Tamosaityte, S; Uckermann, O | 1 |
Lan, X; Li, H; Wang, D; Wen, Y | 1 |
Barminko, J; Gray, A; Grumet, M; Kim, JH; Otsuka, S; Schloss, R; Yarmush, ML | 1 |
Ding, YM; Fang, JL; Feng, YH; Ruan, LQ; Shi, CY; Song, CJ; Yuan, ZG | 1 |
Beattie, MS; Bresnahan, JC; Downing, TL; Farmer, DL; Lee, AL; Li, S; Nout, Y; Wang, A; Yan, ZQ | 1 |
Dhoot, NO; Fischer, I; Han, SS; Kim, D; Murray, M; Shumsky, JS; Tessler, A; Tobias, CA; Tumolo, M; Wheatley, MA | 1 |
Bogdahn, U; Eljaouhari, A; Faber, C; Heckmann, K; Kunz, W; Müller, R; Prang, P; Vroemen, M; Weber, T; Weidner, N | 1 |
Dhoot, NO; Fischer, I; Murray, M; Tessler, A; Tobias, CA; Wheatley, MA | 1 |
15 other study(ies) available for glucuronic acid and Spinal Cord Injuries
Article | Year |
---|---|
Regulated viral BDNF delivery in combination with Schwann cells promotes axonal regeneration through capillary alginate hydrogels after spinal cord injury.
Topics: Alginates; Animals; Axons; Brain-Derived Neurotrophic Factor; Dependovirus; Female; Genetic Vectors; Glucuronic Acid; Hexuronic Acids; Hydrogels; Rats; Rats, Inbred F344; Rats, Transgenic; Regeneration; Schwann Cells; Spinal Cord Injuries; Transduction, Genetic | 2017 |
Axonal outgrowth stimulation after alginate/mesenchymal stem cell therapy in injured rat spinal cord.
Topics: Alginates; Analysis of Variance; Animals; Axons; Biocompatible Materials; Cytokines; Disease Models, Animal; Exploratory Behavior; Flow Cytometry; GAP-43 Protein; Glial Fibrillary Acidic Protein; Glucuronic Acid; Hexuronic Acids; In Vitro Techniques; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Microglia; Organic Chemicals; Psychomotor Performance; Rats; Rats, Wistar; Spinal Cord Injuries | 2017 |
Enhanced neuroregenerative effects by scaffold for the treatment of a rat spinal cord injury with Wnt3a-secreting fibroblasts.
Topics: Alginates; Animals; Axons; Disease Models, Animal; Female; Fibroblasts; Glucuronic Acid; Hexuronic Acids; Nerve Regeneration; Rats; Rats, Wistar; Spinal Cord Injuries; Treatment Outcome; Wnt3A Protein | 2013 |
Injectable alginate hydrogel loaded with GDNF promotes functional recovery in a hemisection model of spinal cord injury.
Topics: Alginates; Animals; Disease Models, Animal; Female; Gait; Glial Cell Line-Derived Neurotrophic Factor; Glucuronic Acid; Hexuronic Acids; Hydrogel, Polyethylene Glycol Dimethacrylate; Injections; Lactic Acid; Microspheres; Neurites; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Long-Evans; Spinal Cord Injuries | 2013 |
Strategies for neurotrophin-3 and chondroitinase ABC release from freeze-cast chitosan-alginate nerve-guidance scaffolds.
Topics: Alginates; Animals; Axons; Chitosan; Chondroitin ABC Lyase; Drug Compounding; Glucuronic Acid; Hexuronic Acids; Neuroglia; Neurons; Neurotrophin 3; Polymers; Spinal Cord Injuries; Tissue Engineering; Tissue Scaffolds | 2017 |
Delivery of Alginate Scaffold Releasing Two Trophic Factors for Spinal Cord Injury Repair.
Topics: Alginates; Animals; Axons; Calcitonin Gene-Related Peptide; Calcium-Binding Proteins; Cluster Analysis; Disease Models, Animal; Glial Fibrillary Acidic Protein; Glucuronic Acid; Hexuronic Acids; Hyperalgesia; Immunohistochemistry; Male; Microfilament Proteins; Motor Activity; Motor Neurons; Neovascularization, Physiologic; Nerve Growth Factors; Proteome; Proteomics; Rats; Recovery of Function; Spinal Cord Injuries; Synaptic Vesicles; Tissue Scaffolds | 2015 |
Characterizing the degradation of alginate hydrogel for use in multilumen scaffolds for spinal cord repair.
Topics: Alginates; Animals; Female; Glucuronic Acid; Guided Tissue Regeneration; Hexuronic Acids; Hydrogel, Polyethylene Glycol Dimethacrylate; Intermediate Filaments; Nitrogen; Polymethyl Methacrylate; Porosity; Rats, Inbred F344; Rheology; Spinal Cord; Spinal Cord Injuries; Tissue Scaffolds | 2016 |
Biochemical Monitoring of Spinal Cord Injury by FT-IR Spectroscopy--Effects of Therapeutic Alginate Implant in Rat Models.
Topics: Alginates; Animals; Calcium; Disease Models, Animal; Drug Implants; Female; Fibrosis; Glucuronic Acid; Hexuronic Acids; Hydrogels; Nerve Regeneration; Rats; Rats, Wistar; Reference Values; Rheology; Spectroscopy, Fourier Transform Infrared; Spinal Cord; Spinal Cord Injuries; Sucrose; Viscosity; White Matter | 2015 |
[Experimental study on bone marrow mesenchymal stem cells seeded in chitosan-alginate scaffolds for repairing spinal cord injury].
Topics: Alginates; Animals; Bone Marrow Cells; Chitosan; Coculture Techniques; Female; Glucuronic Acid; Hexuronic Acids; Male; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Tissue Engineering; Tissue Scaffolds | 2010 |
Encapsulated mesenchymal stromal cells for in vivo transplantation.
Topics: Alginates; Animals; Cell Survival; Cells, Immobilized; Cytokines; Disease Models, Animal; Gene Expression; Gene Expression Profiling; Glucuronic Acid; Hexuronic Acids; Histocytochemistry; Humans; Macrophages; Mesenchymal Stem Cells; Microspheres; Nitric Oxide Synthase Type II; Rats; Spinal Cord Injuries; Transplantation | 2011 |
[Marrow mesenchymal stem cell transplantation with sodium alginate gel for repair of spinal cord injury in mice].
Topics: Alginates; Animals; Disease Models, Animal; Gels; Glucuronic Acid; Hexuronic Acids; Male; Mesenchymal Stem Cell Transplantation; Mice; Mice, Inbred ICR; Spinal Cord Injuries | 2011 |
Drug-eluting microfibrous patches for the local delivery of rolipram in spinal cord repair.
Topics: Alginates; Animals; Anti-Inflammatory Agents; Drug Delivery Systems; Excipients; Female; Glucuronic Acid; Hexuronic Acids; Hydrogels; Lactic Acid; Membranes, Artificial; Phosphodiesterase Inhibitors; Polyesters; Polymers; Propanols; Rats; Rats, Nude; Rolipram; Spinal Cord Injuries; Spinal Cord Regeneration | 2012 |
Alginate encapsulated BDNF-producing fibroblast grafts permit recovery of function after spinal cord injury in the absence of immune suppression.
Topics: Alginates; Animals; Axons; Biocompatible Materials; Capsules; Cell Culture Techniques; Cell Transplantation; Cervical Vertebrae; Female; Fibroblasts; Forelimb; Glucuronic Acid; Graft Rejection; Hexuronic Acids; Hindlimb; Nerve Regeneration; Rats; Rats, Sprague-Dawley; Recovery of Function; Spinal Cord Injuries; Time Factors | 2005 |
The promotion of oriented axonal regrowth in the injured spinal cord by alginate-based anisotropic capillary hydrogels.
Topics: Alginates; Animals; Anisotropy; Axons; Biocompatible Materials; Female; Glucuronic Acid; Hexuronic Acids; Hydrogels; Materials Testing; Nerve Regeneration; Neurons; Rats; Rats, Inbred F344; Spinal Cord Injuries; Stem Cells; Tissue Engineering | 2006 |
Grafting of encapsulated BDNF-producing fibroblasts into the injured spinal cord without immune suppression in adult rats.
Topics: Alginates; Animals; Biocompatible Materials; Brain-Derived Neurotrophic Factor; Capsules; Chick Embryo; Female; Fibroblasts; Gene Expression; Genes, Reporter; Glucuronic Acid; Graft Survival; Hexuronic Acids; Peptides; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Surface-Active Agents | 2001 |